drugset / Trial / NCT00432302

Investigation of Mass Balance of the Test Drug and Major Metabolites

NCT00432302

Phase 1 Completed 7 enrolled Bayer
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to: a) Determine how the body takes up the test drug and distributes it into various body organs and tissues, how it processes the drug and how it ultimately removes it; and b) Examine how well the test drug works against cancer, and whether it is safe and tolerable to take

Timeline

Start
2007-01
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Sagopilone Small molecule 16 mg/m2 Intravenous

Indications